LEADER 01252nam  2200409   450 
001 9910677762203321
005 20230209095521.0
010   $a1-119-56478-6
010   $a1-119-56479-4
035   $a(MiAaPQ)EBC7087566
035   $a(Au-PeEL)EBL7087566
035   $a(CKB)24831707000041
035   $a(EXLCZ)9924831707000041
100   $a20230209d2022      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aGPCRs as therapeutic targets /$fAnnette Gilchrist
210  1$aHoboken, New Jersey :$cJohn Wiley & Sons, Inc.,$d[2022]
210  4$dİ2022
215   $a1 online resource (1049 pages)
311 08$aPrint version: Gilchrist, Annette GPCRs As Therapeutic Targets Newark : John Wiley & Sons, Incorporated,c2022 9781119564744 
606   $aDrug delivery systems
606   $aG proteins$xReceptors
615  0$aDrug delivery systems.
615  0$aG proteins$xReceptors.
676   $a615.6
700   $aGilchrist$b Annette$0930108
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910677762203321
996   $aGPCRs as therapeutic targets$93065335
997   $aUNINA